UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Science (American Association for the Advancement of Science), ISSN 0036-8075, 08/2020, Volume 369, Issue 6504, pp. 643 - 650
General | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Broadly Neutralizing Antibodies - immunology | Coronavirus Infections - prevention & control | Protein Interaction Domains and Motifs - immunology | Receptors, Virus - metabolism | Humans | Middle Aged | Pandemics - prevention & control | Male | Antibodies, Viral - blood | Betacoronavirus - immunology | COVID-19 | Epitopes - immunology | Antibodies, Neutralizing - immunology | SARS-CoV-2 | Protein Domains | Adult | B-Lymphocyte Subsets - immunology | Female | Spike Glycoprotein, Coronavirus - immunology | Receptors, Coronavirus | Antibodies, Monoclonal - immunology | Pneumonia, Viral - therapy | Antibody Affinity | Immunophenotyping | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Antigens, Viral - immunology | Pneumonia, Viral - prevention & control | Coronavirus Infections - therapy | Cell Line, Tumor | Antibodies, Viral - immunology | Immunologic Memory | Aged | Spike Glycoprotein, Coronavirus - chemistry | Antibodies, Neutralizing - blood | Competition | Antigens | Immune response | Spike protein | Severe acute respiratory syndrome | Viral diseases | Antibodies | Viruses | Vaccines | Coronaviruses | Epitopes | Electron microscopy | Impact analysis | Severe acute respiratory syndrome coronavirus 2 | Domains | Proteins | Receptors | Somatic hypermutation | Microscopy | Respiratory diseases | Monoclonal antibodies | Public health | Index Medicus
Journal Article
Nature (London), ISSN 0028-0836, 05/2020, Volume 581, Issue 7809, pp. 465 - 469
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Betacoronavirus - pathogenicity | Pandemics | COVID-19 Testing | Clinical Laboratory Techniques | Humans | Immunoglobulin M - analysis | Virus Shedding | Immunoglobulin M - immunology | Betacoronavirus - immunology | COVID-19 | Feces - virology | Lung - virology | SARS-CoV-2 | Antibodies, Viral - analysis | Immunoglobulin G - immunology | Base Sequence | Blood - virology | Immunoglobulin G - analysis | Viral Envelope Proteins - genetics | Betacoronavirus - isolation & purification | Coronavirus Envelope Proteins | Coronavirus Infections - diagnosis | RNA, Viral - analysis | Pharynx - virology | Sputum - virology | Urine - virology | Hospitalization | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Seroconversion | Viral Load - immunology | Feces - chemistry | Coronavirus Infections - virology | Virus Replication | Pneumonia, Viral - diagnosis | Polymorphism, Single Nucleotide - genetics | Antibodies, Viral - immunology | Betacoronavirus - genetics | Pneumonia, Viral - virology | Medical virology | Hospital patients | Medical examination | Analysis | Tropism | Shedding | Laboratories | Diagnostic tests | Viral diseases | Viruses | Infections | Respiratory tract | Receptors | Throats | Infectivity | Respiratory tract diseases | Containment | Pathogens | RNA viruses | Signs and symptoms | Nucleotide sequence | Severe acute respiratory syndrome | Coronaviruses | Ribonucleic acid--RNA | Patients | Pharynx | Intermediates | Severe acute respiratory syndrome coronavirus 2 | Pathogenicity | Disease transmission | Lungs | Influenza | Respiratory diseases | Sputum | Replication | Viral infections | Index Medicus
Journal Article
Emerging microbes & infections, ISSN 2222-1751, 01/2020, Volume 9, Issue 1, pp. 727 - 732
COVID-19 | pathogenesis | IVIg | SARS-CoV-2 | anticoagulation | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Betacoronavirus - pathogenicity | SARS Virus - immunology | Pandemics | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Severe Acute Respiratory Syndrome - immunology | Antibodies, Viral - blood | Heparin, Low-Molecular-Weight - therapeutic use | Middle East Respiratory Syndrome Coronavirus - immunology | Influenza A Virus, H1N1 Subtype | Cytokines - immunology | Cytokines - metabolism | Pneumonia, Viral - therapy | Anticoagulants - therapeutic use | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Animals | B-Lymphocytes - immunology | Coronavirus Infections - virology | Immunoglobulins, Intravenous - therapeutic use | Coronavirus Infections - therapy | Antibodies, Viral - immunology | T-Lymphocytes - immunology | Mice | Pneumonia, Viral - virology | Immunologic Factors - therapeutic use | Influenza, Human - immunology | Index Medicus
Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 08/2020, Volume 369, Issue 6505, pp. 806 - 811
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Coronavirus Infections - prevention & control | Immunogenicity, Vaccine | Humans | Pandemics - prevention & control | Vaccination | Vaccines, DNA - immunology | Male | Macaca mulatta | Antibodies, Viral - blood | Vaccines, DNA - administration & dosage | Viral Load | Betacoronavirus - immunology | COVID-19 | Antibodies, Neutralizing - immunology | SARS-CoV-2 | Immunization, Secondary | Immunity, Humoral | Betacoronavirus - physiology | Protein Domains | Female | Spike Glycoprotein, Coronavirus - immunology | Mutant Proteins - immunology | Disease Models, Animal | Nasal Mucosa - virology | Spike Glycoprotein, Coronavirus - genetics | Bronchoalveolar Lavage Fluid - virology | Adjuvants, Immunologic | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Viral Vaccines - administration & dosage | Animals | Coronavirus Infections - virology | Pneumonia, Viral - prevention & control | COVID-19 Vaccines | Mutant Proteins - chemistry | Antibodies, Viral - immunology | Immunologic Memory | Immunity, Cellular | Pneumonia, Viral - virology | Spike Glycoprotein, Coronavirus - chemistry | Viral Vaccines - immunology | Antibodies, Neutralizing - blood | Immune response | DNA | Severe acute respiratory syndrome | Genetic research | DNA vaccines | Coronaviruses | Health aspects | Pandemics | Spike protein | Mucosa | Viral diseases | Antibodies | Bronchus | Viruses | Vaccines | Immune response (humoral) | Severe acute respiratory syndrome coronavirus 2 | Proteins | Bronchoalveolar lavage | Prototypes | Neutralizing | Respiratory diseases | Primates | Alveoli | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article
Nature communications, ISSN 2041-1723, 05/2020, Volume 11, Issue 1, pp. 2251 - 2251
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Coronavirus Infections - prevention & control | SARS Virus - immunology | Antibodies, Viral - pharmacology | Receptors, Virus - metabolism | Coronavirus Infections - drug therapy | Epitopes, B-Lymphocyte - chemistry | Humans | Pandemics - prevention & control | Pneumonia, Viral - drug therapy | Antibody Affinity - immunology | Epitopes, B-Lymphocyte - immunology | Betacoronavirus - immunology | COVID-19 | Antibodies, Neutralizing - immunology | SARS-CoV-2 | Betacoronavirus - chemistry | Protein Binding - drug effects | Peptidyl-Dipeptidase A - metabolism | Conserved Sequence | Inhibitory Concentration 50 | Spike Glycoprotein, Coronavirus - immunology | Protein Domains - immunology | Vero Cells | Antibodies, Monoclonal - immunology | Chlorocebus aethiops | Antibodies, Monoclonal - pharmacology | Betacoronavirus - drug effects | Models, Molecular | SARS Virus - drug effects | Antibodies, Neutralizing - pharmacology | Cross Reactions - immunology | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | SARS Virus - chemistry | Angiotensin-Converting Enzyme 2 | Animals | Peptidyl-Dipeptidase A - chemistry | Receptors, Virus - chemistry | Coronavirus Infections - virology | Pneumonia, Viral - prevention & control | Antibodies, Viral - immunology | In Vitro Techniques | Pneumonia, Viral - virology | Spike Glycoprotein, Coronavirus - chemistry | Epidemics | Cell culture | Health services | Medical treatment | Severe acute respiratory syndrome | Viral diseases | Viruses | Coronaviruses | Vaccines | Severe acute respiratory syndrome coronavirus 2 | Respiratory diseases | Neutralizing | Monoclonal antibodies | Index Medicus | Immunotherapy | Virology
Journal Article
Nature (London), ISSN 0028-0836, 08/2020, Volume 584, Issue 7821, pp. 353 - 363
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Betacoronavirus - pathogenicity | Coronavirus Infections - prevention & control | SARS Virus - immunology | Pandemics | Humans | Macaca mulatta | Viral Vaccines - adverse effects | Middle East Respiratory Syndrome Coronavirus - immunology | Orthomyxoviridae - immunology | Betacoronavirus - immunology | COVID-19 | Antibodies, Neutralizing - immunology | SARS-CoV-2 | Immunoglobulin Fc Fragments - immunology | Dengue Virus - immunology | Immunoglobulin G - immunology | Antibodies, Neutralizing - therapeutic use | HEK293 Cells | Antibodies, Neutralizing - adverse effects | Disease Models, Animal | Antibodies, Viral - adverse effects | Antibodies, Viral - therapeutic use | Rats | Antibody-Dependent Enhancement - immunology | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Animals | Coronavirus Infections - virology | COVID-19 Vaccines | Antibodies, Viral - immunology | Mice | Immunoglobulin Fab Fragments - immunology | Pneumonia, Viral - virology | Viral Vaccines - immunology | Complications and side effects | Immunotherapy | Antibody-dependent cell cytotoxicity | Analysis | Epidemics | Medical research | Antiviral agents | Severe acute respiratory syndrome | Vaccination | Antibodies | B cells | Vaccines | Coronaviruses | T cells | Prevention | Virus diseases | Viral antibodies | Medicine, Experimental | Health aspects | Index Medicus
Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 08/2020, Volume 369, Issue 6506, pp. 956 - 963
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Antibody Specificity | Humans | Middle Aged | Pandemics - prevention & control | Antibodies, Monoclonal - therapeutic use | Male | Antibodies, Viral - blood | Viral Load | Betacoronavirus - immunology | COVID-19 | SARS-CoV-2 | Antibodies, Neutralizing - therapeutic use | Peptidyl-Dipeptidase A - metabolism | Protein Domains | Binding Sites | Antibodies, Monoclonal - immunology | Disease Models, Animal | Antibody Affinity | Epitopes | Coronavirus Infections - immunology | Antibodies, Viral - isolation & purification | Antibodies, Neutralizing - isolation & purification | Angiotensin-Converting Enzyme 2 | Coronavirus Infections - virology | Coronavirus Infections - therapy | Immunization, Passive | Spike Glycoprotein, Coronavirus - chemistry | Antibodies, Neutralizing - blood | Coronavirus Infections - prevention & control | Neutralization Tests | Antibodies, Monoclonal - blood | Antibodies, Neutralizing - immunology | Lung - virology | Betacoronavirus - physiology | Mesocricetus | Adult | Female | Spike Glycoprotein, Coronavirus - immunology | Cell Line | Spike Glycoprotein, Coronavirus - metabolism | Antibodies, Viral - therapeutic use | Pneumonia, Viral - therapy | Antibodies, Monoclonal - isolation & purification | Pneumonia, Viral - immunology | Animals | Virus Replication | Pneumonia, Viral - prevention & control | Antibodies, Viral - immunology | Pneumonia, Viral - virology | Prevention | Viral antibodies | Wildlife conservation | Analysis | Severe acute respiratory syndrome | World health | Antibodies | Coronaviruses | B cells | Health aspects | Antigenic determinants | Animal models | Model testing | Prophylaxis | Viral diseases | Animal diseases | Vaccines | Angiotensin-converting enzyme 2--ACE2 | Proteins | Receptors | Peptidyl-dipeptidase A | Public health | Spike protein | Hamsters | Severe acute respiratory syndrome coronavirus 2 | Domains | Neutralizing | Respiratory diseases | Angiotensin | Monoclonal antibodies | Binding sites | Neutralization | Index Medicus
Journal Article
Nature (London), ISSN 0028-0836, 10/2020, Volume 586, Issue 7830, pp. 578 - 3
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Bronchoalveolar Lavage Fluid | Coronavirus Infections - prevention & control | Pandemics - prevention & control | Vaccination | Viral Vaccines - genetics | Macaca mulatta - immunology | Male | Th1 Cells - immunology | Viral Load | Betacoronavirus - immunology | COVID-19 | Macaca mulatta - virology | Lung - virology | SARS-CoV-2 | Immunity, Humoral | Immunoglobulin G - immunology | Adenoviridae - genetics | Female | Spike Glycoprotein, Coronavirus - immunology | Cytokines - immunology | Disease Models, Animal | Lung - pathology | Spike Glycoprotein, Coronavirus - genetics | Coronavirus Infections - genetics | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Viral Vaccines - administration & dosage | Animals | Coronavirus Infections - virology | Pneumonia, Viral - prevention & control | COVID-19 Vaccines | Mice | Immunity, Cellular | Pneumonia, Viral - virology | Viral Vaccines - immunology | Lung - immunology | Rhesus monkey | Viral pneumonia | Control | Immune response | Analysis | Diagnosis | Health aspects | Testing | Pneumonia | Pandemics | Profiling | Immunoglobulin G | Helper cells | Viral diseases | Clinical trials | Vaccines | Middle East respiratory syndrome | Respiratory tract | Bronchoalveolar lavage | Rodents | Alveoli | Immune system | Cytokines | Spike protein | Severe acute respiratory syndrome | Bronchus | Coronaviruses | Immune response (humoral) | Severe acute respiratory syndrome coronavirus 2 | Immunogenicity | Respiratory diseases | Index Medicus
Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 07/2020, Volume 369, Issue 6499, pp. 77 - 81
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Coronavirus Infections - prevention & control | Immunogenicity, Vaccine | Dose-Response Relationship, Immunologic | Immunoglobulin G - blood | Rats, Wistar | Pandemics - prevention & control | Male | Macaca mulatta | Viral Vaccines - adverse effects | Antibodies, Viral - blood | Viral Load | Betacoronavirus - immunology | COVID-19 | Antibodies, Neutralizing - immunology | SARS-CoV-2 | Immunoglobulin G - biosynthesis | Immunoglobulin G - immunology | Female | Vero Cells | Antibodies, Viral - biosynthesis | Chlorocebus aethiops | Betacoronavirus - isolation & purification | Rats | Coronavirus Infections - immunology | Viral Vaccines - administration & dosage | Vaccines, Inactivated - adverse effects | Pilot Projects | Vaccines, Inactivated - immunology | Animals | Coronavirus Infections - virology | Vaccines, Inactivated - administration & dosage | Antibodies, Neutralizing - biosynthesis | Pneumonia, Viral - prevention & control | COVID-19 Vaccines | Antibodies, Viral - immunology | Mice | Mice, Inbred BALB C | Pneumonia, Viral - virology | Viral Vaccines - immunology | Antibodies, Neutralizing - blood | Medical research | Immunization | Pandemics | Severe acute respiratory syndrome | Viral diseases | Antibodies | Viruses | Infections | Monkeys | Vaccines | Coronaviruses | Dosage | Pharynx | Severe acute respiratory syndrome coronavirus 2 | Neutralizing | Respiratory diseases | Primates | Strains (organisms) | Public health | Index Medicus
Journal Article